Clinical trial
Lovastatin Modulation of the Inhibition-excitation Balance in Temporal Lobe Onset Drug Resistant Epilepsy
NCT06789497 is registered in ClinicalTrials.gov with University of Coimbra as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lovastatin Modulation of the Inhibition-excitation Balance in Temporal Lobe Onset Drug Resistant Epilepsy
- Lead sponsor
- University of Coimbra
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 12, 2020
- Completion date
- April 1, 2024
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug resistant epilepsy, temporal lobe epilepsy